Series A - PreciseDx
Investment Firm
Overview
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.
Announced Date
Jan 11, 2022
Funding Type
Series A
Highlights
Location
New York, New York, United States, North America
Social
Participant Investors
4
Round Details and Background
PreciseDx raised $10750000 on 2022-01-11 in Series A
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 11, 2022 |  Series A - PreciseDx | 4 | - | 10.8M |
| Apr 01, 2024 | Series B - PreciseDx | - | 20.7M |
Recent Activity
There is no recent news or activity for this profile.